Biopharmaceuticals. Official position of Russian Association of Endocrinologists
Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet beenadequately reflected in the legal r...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4eeaff4efdb14ba69166bfb8cfbb7594 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4eeaff4efdb14ba69166bfb8cfbb7594 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4eeaff4efdb14ba69166bfb8cfbb75942021-11-14T09:00:18ZBiopharmaceuticals. Official position of Russian Association of Endocrinologists2072-03512072-037810.14341/2072-0351-830https://doaj.org/article/4eeaff4efdb14ba69166bfb8cfbb75942013-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/830https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet beenadequately reflected in the legal regulation of the drug market in the Russian Federation .Editorial team Diabetes MellitusEndocrinology Research Centrearticlerussian association of endocrinologistsbiopharmaceuticalsinsulinbioequivalenceNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 16, Iss 3, Pp 121-122 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
russian association of endocrinologists biopharmaceuticals insulin bioequivalence Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
russian association of endocrinologists biopharmaceuticals insulin bioequivalence Nutritional diseases. Deficiency diseases RC620-627 Editorial team Diabetes Mellitus Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| description |
Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet beenadequately reflected in the legal regulation of the drug market in the Russian Federation . |
| format |
article |
| author |
Editorial team Diabetes Mellitus |
| author_facet |
Editorial team Diabetes Mellitus |
| author_sort |
Editorial team Diabetes Mellitus |
| title |
Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_short |
Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_full |
Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_fullStr |
Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_full_unstemmed |
Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_sort |
biopharmaceuticals. official position of russian association of endocrinologists |
| publisher |
Endocrinology Research Centre |
| publishDate |
2013 |
| url |
https://doaj.org/article/4eeaff4efdb14ba69166bfb8cfbb7594 |
| work_keys_str_mv |
AT editorialteamdiabetesmellitus biopharmaceuticalsofficialpositionofrussianassociationofendocrinologists |
| _version_ |
1718429580148080640 |